VEGF-C was proven to reverse hypercholesterolemia-associated lymphatic dysfunction in apoE−/− mice and to stimulate lymphatic pumping ex vivo in a model of rat mesenteric lymphatics by a VEGFR-3-dependent mechanism31. Here, FLT4 is linked to Hypercholesterolemia.